These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 22532456)

  • 1. Analysis of a membrane-enriched proteome from postmortem human brain tissue in Alzheimer's disease.
    Donovan LE; Higginbotham L; Dammer EB; Gearing M; Rees HD; Xia Q; Duong DM; Seyfried NT; Lah JJ; Levey AI
    Proteomics Clin Appl; 2012 Apr; 6(3-4):201-11. PubMed ID: 22532456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteomics analysis reveals novel components in the detergent-insoluble subproteome in Alzheimer's disease.
    Gozal YM; Duong DM; Gearing M; Cheng D; Hanfelt JJ; Funderburk C; Peng J; Lah JJ; Levey AI
    J Proteome Res; 2009 Nov; 8(11):5069-79. PubMed ID: 19746990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative Analysis of the Brain Ubiquitylome in Alzheimer's Disease.
    Abreha MH; Dammer EB; Ping L; Zhang T; Duong DM; Gearing M; Lah JJ; Levey AI; Seyfried NT
    Proteomics; 2018 Oct; 18(20):e1800108. PubMed ID: 30230243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phosphorylated tau interactome in the human Alzheimer's disease brain.
    Drummond E; Pires G; MacMurray C; Askenazi M; Nayak S; Bourdon M; Safar J; Ueberheide B; Wisniewski T
    Brain; 2020 Sep; 143(9):2803-2817. PubMed ID: 32812023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Global Profiling of Lysine Accessibility to Evaluate Protein Structure Changes in Alzheimer's Disease.
    Yu K; Niu M; Wang H; Li Y; Wu Z; Zhang B; Haroutunian V; Peng J
    J Am Soc Mass Spectrom; 2021 Apr; 32(4):936-945. PubMed ID: 33683887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Label-Free LC-MS/MS Proteomic Analysis of Cerebrospinal Fluid Identifies Protein/Pathway Alterations and Candidate Biomarkers for Amyotrophic Lateral Sclerosis.
    Collins MA; An J; Hood BL; Conrads TP; Bowser RP
    J Proteome Res; 2015 Nov; 14(11):4486-501. PubMed ID: 26401960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteomic landscape of Alzheimer's Disease: novel insights into pathogenesis and biomarker discovery.
    Bai B; Vanderwall D; Li Y; Wang X; Poudel S; Wang H; Dey KK; Chen PC; Yang K; Peng J
    Mol Neurodegener; 2021 Aug; 16(1):55. PubMed ID: 34384464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dissecting Detergent-Insoluble Proteome in Alzheimer's Disease by TMTc-Corrected Quantitative Mass Spectrometry.
    Zaman M; Fu Y; Chen PC; Sun H; Yang S; Wu Z; Wang Z; Poudel S; Serrano GE; Beach TG; Li L; Wang X; Peng J
    Mol Cell Proteomics; 2023 Aug; 22(8):100608. PubMed ID: 37356496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 27-Plex Tandem Mass Tag Mass Spectrometry for Profiling Brain Proteome in Alzheimer's Disease.
    Wang Z; Yu K; Tan H; Wu Z; Cho JH; Han X; Sun H; Beach TG; Peng J
    Anal Chem; 2020 May; 92(10):7162-7170. PubMed ID: 32343560
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteomic signatures of brain regions affected by tau pathology in early and late stages of Alzheimer's disease.
    Mendonça CF; Kuras M; Nogueira FCS; Plá I; Hortobágyi T; Csiba L; Palkovits M; Renner É; Döme P; Marko-Varga G; Domont GB; Rezeli M
    Neurobiol Dis; 2019 Oct; 130():104509. PubMed ID: 31207390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrated proteomics and network analysis identifies protein hubs and network alterations in Alzheimer's disease.
    Zhang Q; Ma C; Gearing M; Wang PG; Chin LS; Li L
    Acta Neuropathol Commun; 2018 Mar; 6(1):19. PubMed ID: 29490708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrated analysis of ultra-deep proteomes in cortex, cerebrospinal fluid and serum reveals a mitochondrial signature in Alzheimer's disease.
    Wang H; Dey KK; Chen PC; Li Y; Niu M; Cho JH; Wang X; Bai B; Jiao Y; Chepyala SR; Haroutunian V; Zhang B; Beach TG; Peng J
    Mol Neurodegener; 2020 Jul; 15(1):43. PubMed ID: 32711556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative proteomics identifies altered O-GlcNAcylation of structural, synaptic and memory-associated proteins in Alzheimer's disease.
    Wang S; Yang F; Petyuk VA; Shukla AK; Monroe ME; Gritsenko MA; Rodland KD; Smith RD; Qian WJ; Gong CX; Liu T
    J Pathol; 2017 Sep; 243(1):78-88. PubMed ID: 28657654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alzheimer disease pathology and the cerebrospinal fluid proteome.
    Dayon L; Núñez Galindo A; Wojcik J; Cominetti O; Corthésy J; Oikonomidi A; Henry H; Kussmann M; Migliavacca E; Severin I; Bowman GL; Popp J
    Alzheimers Res Ther; 2018 Jul; 10(1):66. PubMed ID: 30021611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in the detergent-insoluble brain proteome linked to amyloid and tau in Alzheimer's Disease progression.
    Hales CM; Dammer EB; Deng Q; Duong DM; Gearing M; Troncoso JC; Thambisetty M; Lah JJ; Shulman JM; Levey AI; Seyfried NT
    Proteomics; 2016 Dec; 16(23):3042-3053. PubMed ID: 27718298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteomic Profiling of Plasma and Brain Tissue from Alzheimer's Disease Patients Reveals Candidate Network of Plasma Biomarkers.
    Chen M; Xia W
    J Alzheimers Dis; 2020; 76(1):349-368. PubMed ID: 32474469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deep proteomic network analysis of Alzheimer's disease brain reveals alterations in RNA binding proteins and RNA splicing associated with disease.
    Johnson ECB; Dammer EB; Duong DM; Yin L; Thambisetty M; Troncoso JC; Lah JJ; Levey AI; Seyfried NT
    Mol Neurodegener; 2018 Oct; 13(1):52. PubMed ID: 30286791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Micellar extraction possesses a new advantage for the analysis of Alzheimer's disease brain proteome.
    Musunuri S; Kultima K; Richard BC; Ingelsson M; Lannfelt L; Bergquist J; Shevchenko G
    Anal Bioanal Chem; 2015 Feb; 407(4):1041-57. PubMed ID: 25416231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative proteomic analysis of the frontal cortex in Alzheimer's disease.
    Sathe G; Albert M; Darrow J; Saito A; Troncoso J; Pandey A; Moghekar A
    J Neurochem; 2021 Mar; 156(6):988-1002. PubMed ID: 32614981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative phosphoproteomics of Alzheimer's disease reveals cross-talk between kinases and small heat shock proteins.
    Dammer EB; Lee AK; Duong DM; Gearing M; Lah JJ; Levey AI; Seyfried NT
    Proteomics; 2015 Jan; 15(2-3):508-519. PubMed ID: 25332170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.